131 related articles for article (PubMed ID: 26491058)
1. An Evaluation of Alternative Markers to Guide Initiation of Anti-retroviral Therapy in HIV-Infected Children in Settings where CD4 Assays are not Available.
Huibers MH; Moons P; Maseko N; Gushu MB; Wit FW; Graham SM; van Hensbroek MB; Calis JC
J Trop Pediatr; 2016 Feb; 62(1):19-28. PubMed ID: 26491058
[TBL] [Abstract][Full Text] [Related]
2. Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi.
Gitura B; Joshi MD; Lule GN; Anzala O
East Afr Med J; 2007 Oct; 84(10):466-72. PubMed ID: 18232267
[TBL] [Abstract][Full Text] [Related]
3. Comparison of previous and present World Health Organization clinical staging criteria in HIV-infected Malawian children.
Poerksen G; Nyirenda M; Pollock L; Blencowe H; Tembo P; Chesshyre E; Jefferis O; Kenny J; Moons P; Bunn J; Molyneux E
AIDS; 2009 Sep; 23(14):1913-6. PubMed ID: 19584702
[TBL] [Abstract][Full Text] [Related]
4. Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania.
Johnson OO; Benjamin DK; Benjamin DK; Schimana W; Tillekeratne LG; Crump JA; Landman KZ; Kinabo GD; Mmbaga B; Msuya LJ; Shao JF; Swai ME; Cunningham CK
Pediatr Infect Dis J; 2009 Jun; 28(6):493-7. PubMed ID: 19436238
[TBL] [Abstract][Full Text] [Related]
5. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
Shah I; Parikh S
J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
[TBL] [Abstract][Full Text] [Related]
6. Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting.
Oudenhoven HP; Meijerink H; Wisaksana R; Oetojo S; Indrati A; van der Ven AJ; van Asten HA; Alisjahbana B; van Crevel R
Trop Med Int Health; 2011 Nov; 16(11):1372-9. PubMed ID: 21883724
[TBL] [Abstract][Full Text] [Related]
7. Total lymphocyte count as a surrogate marker to predict CD4 count in human immunodeficiency virus-infected children: a retrospective evaluation.
Wang Y; Li Y; Wang C; Liang S; Guo J; Li Z; Zhang M; Li W
Pediatr Infect Dis J; 2012 Jan; 31(1):61-3. PubMed ID: 22217967
[TBL] [Abstract][Full Text] [Related]
8. Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.
Gupta A; Gupte N; Bhosale R; Kakrani A; Kulkarni V; Nayak U; Thakar M; Sastry J; Bollinger RC;
J Acquir Immune Defic Syndr; 2007 Nov; 46(3):338-42. PubMed ID: 17846559
[TBL] [Abstract][Full Text] [Related]
9. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
Susaengrat W; Mitchai M; Leerattanapetch N
J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
[TBL] [Abstract][Full Text] [Related]
10. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
11. Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility.
Callens SF; Kitetele F; Lusiama J; Shabani N; Edidi S; Colebunders R; Behets F; Van Rie A
BMC Infect Dis; 2008 Mar; 8():31. PubMed ID: 18325119
[TBL] [Abstract][Full Text] [Related]
12. Correlation analysis on total lymphocyte count and CD4 count of HIV-infected patients.
Liu FR; Guo F; Ye JJ; Xiong CF; Zhou PL; Yin JG; Ye LX
Int J Clin Pract; 2008 Jun; 62(6):955-60. PubMed ID: 17983435
[TBL] [Abstract][Full Text] [Related]
13. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.
Bigna JJ; Plottel CS; Koulla-Shiro S
Infect Dis Poverty; 2016 Sep; 5(1):85. PubMed ID: 27593965
[TBL] [Abstract][Full Text] [Related]
14. Long-term effectiveness of combination antiretroviral therapy and prevalence of HIV drug resistance in HIV-1-infected children and adolescents in Rwanda.
Mutwa PR; Boer KR; Rusine J; Muganga N; Tuyishimire D; Schuurman R; Reiss P; Lange JM; Geelen SP
Pediatr Infect Dis J; 2014 Jan; 33(1):63-9. PubMed ID: 24352189
[TBL] [Abstract][Full Text] [Related]
15. Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya.
Githinji N; Maleche-Obimbo E; Nderitu M; Wamalwa DC; Mbori-Ngacha D
BMC Infect Dis; 2011 Sep; 11():259. PubMed ID: 21961890
[TBL] [Abstract][Full Text] [Related]
16. Predicting CD4 lymphocyte count <200 cells/mm(3) in an HIV type 1-infected African population.
Morpeth SC; Crump JA; Shao HJ; Ramadhani HO; Kisenge PR; Moylan CA; Naggie S; Caram LB; Landman KZ; Sam NE; Itemba DK; Shao JF; Bartlett JA; Thielman NM
AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1230-6. PubMed ID: 17961109
[TBL] [Abstract][Full Text] [Related]
17. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
Kamya MR; Semitala FC; Quinn TC; Ronald A; Njama-Meya D; Mayanja-Kizza H; Katabira ET; Spacek LA
Afr Health Sci; 2004 Aug; 4(2):94-101. PubMed ID: 15477187
[TBL] [Abstract][Full Text] [Related]
18. The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Dec; 9(2):128-33. PubMed ID: 17319344
[TBL] [Abstract][Full Text] [Related]
19. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012.
Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D;
AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124
[TBL] [Abstract][Full Text] [Related]
20. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.
Bishai D; Colchero A; Durack DT
AIDS; 2007 Jun; 21(10):1333-40. PubMed ID: 17545710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
